These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38735576)

  • 1. A new compound, phomaherbarine A, induces cytolytic reactivation in epstein-barr virus-positive B cell lines.
    Bae SE; Choi JW; Hong JW; Ku H; Sim KY; Ko GH; Jang DS; Shim SH; Park SG
    Antiviral Res; 2024 Jul; 227():105906. PubMed ID: 38735576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas.
    Feng WH; Hong G; Delecluse HJ; Kenney SC
    J Virol; 2004 Feb; 78(4):1893-902. PubMed ID: 14747554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Mechanism-Based Targeted Screen To Identify Epstein-Barr Virus-Directed Antiviral Agents.
    Li X; Akinyemi IA; You JK; Rezaei MA; Li C; McIntosh MT; Del Poeta M; Bhaduri-McIntosh S
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32796077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)- induced lymphoproliferative disease and lytic viral replication.
    Bilger A; Plowshay J; Ma S; Nawandar D; Barlow EA; Romero-Masters JC; Bristol JA; Li Z; Tsai MH; Delecluse HJ; Kenney SC
    Oncotarget; 2017 Jul; 8(27):44266-44280. PubMed ID: 28574826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignancies.
    Westphal EM; Blackstock W; Feng W; Israel B; Kenney SC
    Cancer Res; 2000 Oct; 60(20):5781-8. PubMed ID: 11059774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: a basis for new therapies.
    Giunco S; Dolcetti R; Keppel S; Celeghin A; Indraccolo S; Dal Col J; Mastorci K; De Rossi A
    Clin Cancer Res; 2013 Apr; 19(8):2036-47. PubMed ID: 23444223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valpromide Inhibits Lytic Cycle Reactivation of Epstein-Barr Virus.
    Gorres KL; Daigle D; Mohanram S; McInerney GE; Lyons DE; Miller G
    mBio; 2016 Mar; 7(2):e00113. PubMed ID: 26933051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin induces lytic cytotoxicity in Epstein-Barr virus-positive cells.
    Liu SF; Wang H; Li ZJ; Deng XY; Xiang H; Tao YG; Li W; Tang M; Cao Y
    Eur J Pharmacol; 2008 Jul; 589(1-3):8-13. PubMed ID: 18571159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dipyridamole as a new drug to prevent Epstein-Barr virus reactivation.
    Thomé MP; Borde C; Larsen AK; Henriques JAP; Lenz G; Escargueil AE; Maréchal V
    Antiviral Res; 2019 Dec; 172():104615. PubMed ID: 31580916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted eradication of EBV-positive cancer cells by CRISPR/dCas9-mediated EBV reactivation in combination with ganciclovir.
    Sugiokto FG; Li R
    mBio; 2024 Jul; 15(7):e0079524. PubMed ID: 38874417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of lytic Epstein-Barr virus (EBV) infection by synergistic action of rituximab and dexamethasone renders EBV-positive lymphoma cells more susceptible to ganciclovir cytotoxicity in vitro and in vivo.
    Daibata M; Bandobashi K; Kuroda M; Imai S; Miyoshi I; Taguchi H
    J Virol; 2005 May; 79(9):5875-9. PubMed ID: 15827204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors.
    Kerr JR
    J Clin Pathol; 2019 Oct; 72(10):651-658. PubMed ID: 31315893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a new class of small molecules that efficiently reactivate latent Epstein-Barr Virus.
    Tikhmyanova N; Schultz DC; Lee T; Salvino JM; Lieberman PM
    ACS Chem Biol; 2014 Mar; 9(3):785-95. PubMed ID: 24028149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters.
    Reusch JA; Nawandar DM; Wright KL; Kenney SC; Mertz JE
    J Virol; 2015 Feb; 89(3):1731-43. PubMed ID: 25410866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic Activation of Lytic Epstein-Barr Virus Gene Expression without Virion Production.
    Lee J; Kosowicz JG; Hayward SD; Desai P; Stone J; Lee JM; Liu JO; Ambinder RF
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31341058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein--Barr virus post-transplant lymphoproliferative disease and virus-specific therapy: pharmacological re-activation of viral target genes with arginine butyrate.
    Mentzer SJ; Perrine SP; Faller DV
    Transpl Infect Dis; 2001 Sep; 3(3):177-85. PubMed ID: 11493400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of targeting sumoylation processes during latent and induced Epstein-Barr virus infections using the small molecule inhibitor ML-792.
    Garcia P; Harrod A; Jha S; Jenkins J; Barnhill A; Lee H; Thompson M; Williams JP; Barefield J; Mckinnon A; Suarez P; Shah A; Lowrey AJ; Bentz GL
    Antiviral Res; 2021 Apr; 188():105038. PubMed ID: 33577806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytolytic virus activation therapy and treatment monitoring for Epstein-Barr virus associated nasopharyngeal carcinoma in a mouse tumor model.
    Novalić Z; Verkuijlen SAWM; Verlaan M; Eersels JLH; de Greeuw I; Molthoff CFM; Middeldorp JM; Greijer AE
    J Med Virol; 2017 Dec; 89(12):2207-2216. PubMed ID: 28853217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone Loaders CAF1 and HIRA Restrict Epstein-Barr Virus B-Cell Lytic Reactivation.
    Zhang Y; Jiang C; Trudeau SJ; Narita Y; Zhao B; Teng M; Guo R; Gewurz BE
    mBio; 2020 Oct; 11(5):. PubMed ID: 33109754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IRF4 promotes Epstein-Barr virus activation in Burkitt's lymphoma cells.
    Gao Y; Wang L; Lei Z; Li J; Forrest JC; Liang X
    J Gen Virol; 2019 May; 100(5):851-862. PubMed ID: 30907723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.